Alkermes Announces Positive Topline Results From REVITALYZSM Phase 3 Study Evaluating LUMRYZ® (sodium oxybate) Extended-Release in Adults With Idiopathic Hypersomnia May 12, 2026 anxiety ONLY AVAILABLE IN PAID PLANS. Originally reported by biospace. Read more Source: https://www.biospace.com/press-releases/alkermes-announces-positive-topline-results-from-revitalyz-phase-3-study-evaluating-lumryz-sodium-oxybate-extended-release-in-adults-with-idiopathic-hypersomnia
